Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Mass spectrometry device and method using ion-molecule reaction ionization
Virtual physician acute myocardial infarction detection system and method
Artifact removal in nuclear images
Method and system for distributing load by redirecting traffic
Method and system for video parameter analysis and transmission
Frequency offset estimation apparatus and method of OFDM system
System and method for managing a loyalty program via an association network infrastructure
  Randomly Featured Patents
Multi-level error diffusion apparatus and method of using same
Hermetic compressor
Dumbbell shaped bottle
Refuelable battery-powered electric vehicle
Method of manufacturing a filter
Thin film photovoltaic device
Composite semiconductor structure for reducing scattering of carriers by optical phonons and a semiconductor device that uses such a composite semiconductor structure
Modular design method and apparatus